6 November 2015 - Gilead and AbbVie have been contacted by the U.S. government’s Medicaid agency to discuss options for how to pay for hepatitis C cures whose costs have eaten into state budgets.

For more details, go to: http://www.bloomberg.com/news/articles/2015-11-05/gilead-abbvie-asked-by-medicaid-for-hepatitis-c-pricing-options